Physician

Kevin J Nusz, M.D.

According to 2025 Medicare claims, Kevin Nusz, M.D. (NPI: 1548229305) practices ophthalmology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Lancaster, SC. This provider's primary affiliated billing organization is LANCASTER EYE CLINIC P.A. (NPI: 1730140625; TIN: 57-0738713) and primary practice location at 29720-2200.

Nusz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,054 traditional Medicare patients, billed 3,534 HCPCS/CPT codes, and received $398,062 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,772 prescription claims across 441 beneficiaries totaling $160,608 in drug costs, led by Restasis (Cyclosporine). DME data shows 42 claims. Open Payments data shows 34 records totaling $2,400. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $126,197 to $160,608. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	784	3,554	$377,821
2016	855	3,938	$385,175
2017	941	4,335	$413,625
2018	1,246	4,507	$574,550
2019	1,372	4,636	$552,296
2020	1,360	4,135	$468,607
2021	1,183	3,631	$458,291
2022	1,020	3,480	$411,877
2023	1,077	3,347	$423,098
2024	1,054	3,534	$398,062

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	280	1,072	$126,197
2016	310	1,255	$116,803
2017	270	1,117	$112,315
2018	330	1,391	$120,190
2019	324	1,235	$118,905
2020	344	1,343	$146,278
2021	337	1,355	$145,563
2022	310	1,312	$306,461
2023	320	1,454	$263,614
2024	441	1,772	$160,608

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	93	93	$4,828
2016	73	73	$2,414
2017	105	105	$4,641
2018	N/R	N/R	N/R
2019	25	25	$1,207
2020	12	12	$775
2021	50	50	$2,813
2022	22	22	$1,212
2023	32	32	$1,432
2024	40	42	$2,512

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	313	406	$93
92014	Established patient complete exam of visual system	665	705	$79
92083	Exam of visual field with extended testing	194	209	$45
92136	Measurement of corneal curvature and depth of eye	162	275	$31
92133	Imaging of optic nerve	201	209	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	38	2,280	$46,897
Vyzulta	Latanoprostene Bunod	66	2,521	$23,243
Xiidra	Lifitegrast	19	990	$21,976
Lumigan	Bimatoprost	27	1,111	$9,896
Prednisolone Acetate	Prednisolone Acetate	217	5,759	$7,449

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	N	17	18	$1,466
V2020	Frames, purchases	N	23	24	$1,047

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$2,400	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin J. Nusz, M.D.?

Tedicare shows public-source Medicare data for Kevin J. Nusz, M.D. (NPI 1548229305), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin J. Nusz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin J. Nusz, M.D.?

Kevin J. Nusz, M.D. is linked to LANCASTER EYE CLINIC P.A. (billing NPI 1730140625) in the available physician profile data.

Does Kevin J. Nusz, M.D. have Open Payments data?

Kevin J. Nusz, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.